报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 80.52% | -0.95% | 1.51% | 7/129 | 51.32% | 佰仁医疗 | 85.72% | 行业排名> |
2024-12-31 | 79.33% | -3.27% | 1.42% | 9/129 | 52.31% | 佰仁医疗 | 88.34% | 行业排名> |
2024-09-30 | 78.22% | -3.46% | -0.81% | 9/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 78.85% | -1.22% | -3% | 8/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 81.29% | 0.91% | -0.87% | 5/129 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 82.01% | -2.38% | 1.22% | 5/129 | 53.5% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 81.02% | -4.99% | 1.49% | 8/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 79.83% | -6.54% | -0.9% | 10/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 80.56% | -3.97% | -4.11% | 8/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 84.01% | 1.97% | -1.49% | 5/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 85.27% | 4.09% | -0.17% | 5/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 85.42% | 4.99% | 1.82% | 4/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 83.89% | 4.1% | 1.82% | 6/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 82.39% | -1.31% | 0.57% | 10/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 81.92% | -2.87% | 0.69% | 10/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 81.36% | 2% | 0.95% | 11/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 80.59% | -0.35% | -3.47% | 12/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 83.48% | -2.44% | -1.02% | 10/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 84.34% | 2% | 4.29% | 9/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-03-31 | 80.87% | 2% | -5.49% | 11/129 | 58.33% | 正海生物 | 92.61% | 行业排名> |
2019-12-31 | 85.57% | 3.78% | 3.78% | 9/129 | 56.37% | 正海生物 | 94.38% | 行业排名> |
2018-12-31 | 82.46% | -1.67% | -1.67% | 10/129 | 55.53% | 正海生物 | 93.12% | 行业排名> |
2017-12-31 | 83.86% | 2% | 2% | 4/129 | 55.34% | 正海生物 | 93.78% | 行业排名> |